Microbio Co Ltd (4128) - Total Assets
Based on the latest financial reports, Microbio Co Ltd (4128) holds total assets worth NT$12.33 Billion TWD (≈ $388.58 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can Microbio Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Microbio Co Ltd - Total Assets Trend (2006–2025)
This chart illustrates how Microbio Co Ltd's total assets have evolved over time, based on quarterly financial data. See Microbio Co Ltd shareholders equity for net asset value and shareholders' equity analysis.
Microbio Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Microbio Co Ltd's total assets of NT$12.33 Billion consist of 27.6% current assets and 72.4% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 5.8% |
| Accounts Receivable | NT$41.54 Million | 0.3% |
| Inventory | NT$260.99 Million | 2.1% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$110.64 Million | 0.9% |
| Goodwill | NT$39.41 Million | 0.3% |
Asset Composition Trend (2006–2025)
This chart illustrates how Microbio Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Microbio Co Ltd market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Microbio Co Ltd's current assets represent 27.6% of total assets in 2025, a decrease from 54.3% in 2006.
- Cash Position: Cash and equivalents constituted 5.8% of total assets in 2025, down from 29.6% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 6.0% in 2006.
- Asset Diversification: The largest asset category is inventory at 2.1% of total assets.
Microbio Co Ltd Competitors by Total Assets
Key competitors of Microbio Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nestle S.A.
SW:NESN
|
Switzerland | CHF127.15 Billion |
|
Unibel S.A
PA:UNBL
|
France | €4.09 Billion |
|
Sanquan Food Co Ltd
SHE:002216
|
China | CN¥7.57 Billion |
|
Xiamen Kingdomway Group Co
SHE:002626
|
China | CN¥8.38 Billion |
|
Grupo Herdez S.A.B. de C.V
MX:HERDEZ
|
Mexico | MX$35.95 Billion |
|
Bellring Brands LLC
NYSE:BRBR
|
USA | $1.03 Billion |
|
Beijing Sanyuan Foods Co Ltd
SHG:600429
|
China | CN¥8.86 Billion |
|
Kri-Kri Milk Industry S.A
AT:KRI
|
Greece | €219.80 Million |
Microbio Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.30 | 5.85 | 10.59 |
| Quick Ratio | 3.97 | 5.44 | 10.15 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$2.61 Billion | NT$2.60 Billion | NT$3.90 Billion |
Microbio Co Ltd - Advanced Valuation Insights
This section examines the relationship between Microbio Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.99 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -11.4% |
| Total Assets | NT$12.33 Billion |
| Market Capitalization | $256.65 Million USD |
Valuation Analysis
Below Book Valuation: The market values Microbio Co Ltd's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Microbio Co Ltd's assets decreased by 11.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Microbio Co Ltd (2006–2025)
The table below shows the annual total assets of Microbio Co Ltd from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | NT$12.33 Billion ≈ $388.58 Million |
-11.44% |
| 2024-12-31 | NT$13.93 Billion ≈ $438.78 Million |
-5.48% |
| 2023-12-31 | NT$14.74 Billion ≈ $464.24 Million |
-2.36% |
| 2022-12-31 | NT$15.09 Billion ≈ $475.44 Million |
+0.49% |
| 2021-12-31 | NT$15.02 Billion ≈ $473.11 Million |
+7.84% |
| 2020-12-31 | NT$13.93 Billion ≈ $438.73 Million |
+38.54% |
| 2019-12-31 | NT$10.05 Billion ≈ $316.68 Million |
-1.77% |
| 2018-12-31 | NT$10.23 Billion ≈ $322.40 Million |
+11.71% |
| 2017-12-31 | NT$9.16 Billion ≈ $288.60 Million |
-1.04% |
| 2016-12-31 | NT$9.26 Billion ≈ $291.64 Million |
-5.86% |
| 2015-12-31 | NT$9.83 Billion ≈ $309.79 Million |
+0.90% |
| 2014-12-31 | NT$9.75 Billion ≈ $307.03 Million |
+2.16% |
| 2013-12-31 | NT$9.54 Billion ≈ $300.53 Million |
+31.37% |
| 2012-12-31 | NT$7.26 Billion ≈ $228.77 Million |
+9.27% |
| 2011-12-31 | NT$6.65 Billion ≈ $209.36 Million |
+20.10% |
| 2010-12-31 | NT$5.53 Billion ≈ $174.33 Million |
-6.18% |
| 2009-12-31 | NT$5.90 Billion ≈ $185.82 Million |
+160.04% |
| 2008-12-31 | NT$2.27 Billion ≈ $71.46 Million |
+30.51% |
| 2007-12-31 | NT$1.74 Billion ≈ $54.75 Million |
+116.92% |
| 2006-12-31 | NT$801.18 Million ≈ $25.24 Million |
-- |
About Microbio Co Ltd
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. It also involved in the trading of organic foods; sale of beverages; pr… Read more